Teikoku Pharma USA, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.teikokuusa.com
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
- Conditions
- Agitation
- Interventions
- Drug: 6 cm2 - 1 Active and 1 Placebo DMTS PatchesDrug: Placebo - 2 Placebo DMTS PatchesDrug: 12 cm2 - 2 Active DMTS Patches
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06052254
Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty
- Conditions
- Pain, Postoperative
- Interventions
- Drug: DMTS PatchDrug: Placebo Patch
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 182
- Registration Number
- NCT05412992
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty
- Conditions
- Pain, Postoperative
- Interventions
- Drug: DMTSDrug: Placebo
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 164
- Registration Number
- NCT04242407
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸HD Research, Bellaire, Texas, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy
- Conditions
- Pain, Postoperative
- Interventions
- Drug: PlaceboDrug: DMTS
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT02953054
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
🇦🇺Nucleus Network LTD, Melbourne, Victoria, Australia
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
- Conditions
- Irritation/Irritant
- Interventions
- Drug: 350 mg Donepezil Transdermal PatchDrug: Placebo Patch
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00916383
- Locations
- 🇺🇸
Margolin Brain Institute, Fresno, California, United States
🇺🇸Miami Jewish Home and Hospital for the Aged, Miami, Florida, United States
🇺🇸Xenoscience, Inc, Phoenix, Arizona, United States
Flurbiprofen Tape for Treatment of Chronic Low Back Pain
- Conditions
- Chronic Low Back Pain
- Interventions
- Drug: Placebo Tape (Arm 1)Drug: Placebo Tape (Arm 3)
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2016-10-06
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 127
- Registration Number
- NCT00759330
- Locations
- 🇺🇸
Sarah Cannon Research Institute, Memphis, Tennessee, United States
🇺🇸Internal Medicine Associates of Cordova, Cordova, Tennessee, United States
🇺🇸Rainier Clinical Research Center, Inc., Renton, Washington, United States
Study of a New Dressing for Use With Topical Medications
- Conditions
- Psoriasis
- First Posted Date
- 2005-10-07
- Last Posted Date
- 2008-07-02
- Lead Sponsor
- Teikoku Pharma USA, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00234728
- Locations
- 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States